ID: ALA1161625

Max Phase: Preclinical

Molecular Formula: C12H10O4

Molecular Weight: 218.21

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C#CCc1cccc(C(=O)O)c1OC(C)=O

Standard InChI:  InChI=1S/C12H10O4/c1-3-5-9-6-4-7-10(12(14)15)11(9)16-8(2)13/h1,4,6-7H,5H2,2H3,(H,14,15)

Standard InChI Key:  WSTAJRBIKYXDPN-UHFFFAOYSA-N

Associated Targets(non-human)

Glutathione reductase 26 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 218.21Molecular Weight (Monoisotopic): 218.0579AlogP: 1.49#Rotatable Bonds: 3
Polar Surface Area: 63.60Molecular Species: ACIDHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.37CX Basic pKa: CX LogP: 1.83CX LogD: -1.58
Aromatic Rings: 1Heavy Atoms: 16QED Weighted: 0.47Np Likeness Score: 0.12

References

1. Ott I, Schmidt K, Kircher B, Schumacher P, Wiglenda T, Gust R..  (2005)  Antitumor-active cobalt-alkyne complexes derived from acetylsalicylic acid: studies on the mode of drug action.,  48  (2): [PMID:15658875] [10.1021/jm049326z]

Source